Brief Strategic Family Therapy for Adolescent Drug Abusers - Full Text View

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Miami
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00095303

Purpose

The purpose of this study is to compare Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abusers to treatment as usual (TAU).

Condition	Intervention	Phase
Substance Abuse	Behavioral: Brief Strategic Family Therapy For Adolescent Drug Abusers Behavioral: Treatment as Usual	Phase III

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Subject), Parallel Assignment, Safety/Efficacy Study
Official Title:	Brief Strategic Family Therapy for Adolescent Drug Abusers

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Drug abstinence [ Time Frame: 10 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Engagement in treatment activities [ Time Frame: 4 months ] [ Designated as safety issue: No ]
Externalizing of problem behaviors [ Time Frame: 10 months ] [ Designated as safety issue: No ]
Risky sexual behaviors [ Time Frame: 10 months ] [ Designated as safety issue: No ]
Level of pro-social activities [ Time Frame: 10 months ] [ Designated as safety issue: No ]
Level of family functioning [ Time Frame: 10 months ] [ Designated as safety issue: No ]

Enrollment:	481
Study Start Date:	August 2004
Study Completion Date:	January 2008
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
BSFT: Experimental	Behavioral: Brief Strategic Family Therapy For Adolescent Drug Abusers BSFT is a family therapy approach that consists of 12 to 16 sessions (each 1 to 1.5 hours long) over a 4-month period, and up to 8 "booster" sessions. Interventions are delivered to adolescents and relevant family members in non-restrictive community settings (e.g., clinics, homes, school).
Treatment as Usual: Active Comparator	Behavioral: Treatment as Usual TAU varies depending on site, however each will offer services that include at least 1 therapy session per week (individual or group therapy) as well as participation in ancillary services (e.g., case management, AA, etc.) over a four month period.

Detailed Description:

Adolescent drug abuse continues to be one of the most pressing public health issues in the United States—our nation's teenagers continue to use illicit drugs at a worrisome rate. Broad reviews of the treatment outcome literature indicate that family interventions in general, and Brief Strategic Family Therapy (BSFT) in particular, are effective with drug using youth. This study is designed to compare BSFT to treatment as usual (TAU). The researchers believe that BSFT will be much more effective than TAU in reducing adolescent drug use. They will also examine which of these treatment approaches does a better job of engaging adolescents and family members in treatment, decreasing problem behaviors, decreasing sexually risky behaviors, increasing pro-social activities (e.g., school, work), and improving the functioning of the family.

Eligibility

Ages Eligible for Study:	12 Years to 17 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

used any illicit drugs (other than alcohol and tobacco) in the 30-day period
live with or intend to live with a formal or informal family

Exclusion Criteria:

Use opiates more than 2 times per week at the time of the baseline
Suicidal or homicidal ideation.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00095303

Locations

United States, Arizona
La Frontera Center
Tucson, Arizona, United States, 85713
United States, California
Tarzana Treatment Center
Tarzana, California, United States, 91356
United States, Colorado
Arapahoe House
Thornton, Colorado, United States, 80260
United States, Florida
Gateway Community Services
Jacksonville, Florida, United States, 32224
The Villiage
Miami, Florida, United States, 33137
United States, North Carolina
Daymark
Concord, North Carolina, United States, 28025
United States, Ohio
The Crossroads Center
Cincinnati, Ohio, United States, 45219
Puerto Rico
Centro de Salud Mental de la Comunidad de Bayamsn
Bayamon, Puerto Rico, 00960

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Miami

Investigators

Principal Investigator:

Jose Szapocznik, Ph.D.

University of Miami

More Information

No publications provided

Responsible Party:	University of Miami ( Josė Szapocznik, Ph.D. )
Study ID Numbers:	NIDA-CTN-0014
Study First Received:	November 2, 2004
Last Updated:	December 16, 2008
ClinicalTrials.gov Identifier:	NCT00095303 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

Additional relevant MeSH terms:

Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on May 07, 2009